z-logo
Premium
α 5 β 1 integrin stimulates Bcl‐2 expression and cell survival through Akt, focal adhesion kinase, and Ca 2+ /calmodulin‐dependent protein kinase IV
Author(s) -
Lee ByungHeon,
Ruoslahti Erkki
Publication year - 2005
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.20488
Subject(s) - protein kinase b , focal adhesion , microbiology and biotechnology , pi3k/akt/mtor pathway , integrin , camk , biology , signal transduction , kinase , creb , protein kinase a , chemistry , cancer research , transcription factor , receptor , biochemistry , gene , autophosphorylation
CHO cells expressing α 5 β 1 integrin are more resistant to apoptosis and express more Bcl‐2 than the same cells engineered to express α v β 1 or cytoplasmically truncated α 5 Δcβ 1 integrin as their main fibronectin receptor. The Bcl‐2 up‐regulation by α 5 β 1 is mediated, at least in part, by the focal adhesion kinase (FAK) and phosphatidylinositol‐3 kinase (PI3K)/Akt pathways. Here, we show that integrin‐mediated activation of Ca 2+ /calmodulin‐dependent protein kinase (CaMK) IV, and the NF‐κB and CREB transcription factors also enhance the integrin‐dependent regulation of Bcl‐2 expression in the α 5 β 1 cells. A forkhead transcription factor, which is inactivated by Akt, blocked Bcl‐2 expression. The FAK pathway was found to be defective in both the α v β 1 and α 5 Δcβ 1 cells. These cell lines differed from one another in two Bcl‐2‐regulating pathways: adhesion through α v β 1 failed to activate Akt, allowing forkhead to suppress Bcl‐2 transcription, whereas α 5 Δcβ 1 did not activate NF‐κB and CREB, presumably because CaMK IV was not activated. Our results indicate that three pathways, the FAK, PI3K/Akt, and CaMK IV mediate the survival‐supporting activity of α 5 β 1 integrin. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom